$LASE
Laser Photonics Corp Stock $lase

$lase Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000165495424004797 Filed on April 19, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$623.4K	$494.8K	$3.939M
YoY Change	-35.6%	-57.51%	-20.49%
Cost Of Revenue	$308.1K	$631.1K	$1.489M
YoY Change	8.53%	8.14%	-28.66%
Gross Profit	$315.4K	-$136.3K	$2.450M
YoY Change	-53.91%	-123.47%	-14.54%
Gross Profit Margin	50.58%	-27.55%	62.19%
Selling, General & Admin	$1.881M	$550.6K	$3.899M
YoY Change	116.72%	-77.16%	11.35%
% of Gross Profit	596.59%		159.15%
Research & Development	$60.23K	$202.3K	$202.3K
YoY Change	49.81%		100.65%
% of Gross Profit	19.1%		8.26%
Depreciation & Amortization	$245.9K	$187.1K	$1.214M
YoY Change	143.6%	116.54%	982.36%
% of Gross Profit	77.97%		49.56%
Operating Expenses	$2.426M	$1.160M	$6.246M
YoY Change	270.55%	-53.53%	62.36%
Operating Profit	-$2.111M	-$1.297M	-$3.796M
YoY Change	-7272.41%	-32.33%	287.38%
Interest Expense		$0.00	$0.00
YoY Change			-100.0%
% of Operating Profit
Other Income/Expense, Net	-$2.723K	$30.06K	$220.3K
YoY Change	326.13%	-20140.0%	-1356.05%
Pretax Income	-$2.114M	-$1.267M	-$3.766M
YoY Change	-7441.05%	-33.91%	277.55%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$2.114M	-$1.267M	-$3.766M
YoY Change	-7441.05%	-33.43%	277.55%
Net Earnings / Revenue	-339.02%	-255.95%	-95.59%
Basic Earnings Per Share	-$0.20
Diluted Earnings Per Share	-$0.20	-$0.14	-$0.42
COMMON SHARES
Basic Shares Outstanding	9.270M shares	8.253M shares
Diluted Shares Outstanding	10.59M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.748M	$6.201M	$6.201M
YoY Change	-72.2%	-49.1%	-49.1%
Cash & Equivalents	$2.748M	$6.201M	$6.201M
Short-Term Investments
Other Short-Term Assets	$405.6K	$39.19K	$39.19K
YoY Change	-89.74%
Inventory	$2.105M	$2.278M	$2.278M
Prepaid Expenses
Receivables	$446.0K	$816.4K	$816.4K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.705M	$9.335M	$9.335M
YoY Change	-58.77%	-38.68%	-38.68%
LONG-TERM ASSETS
Property, Plant & Equipment	$923.7K	$952.8K	$1.550M
YoY Change	24.47%	51.76%	6.17%
Goodwill
YoY Change
Intangibles	$4.078M	$4.280M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$5.376M	$5.830M	$5.830M
YoY Change	26.7%	30.38%	30.38%
TOTAL ASSETS
Total Short-Term Assets	$5.705M	$9.335M	$9.335M
Total Long-Term Assets	$5.376M	$5.830M	$5.830M
Total Assets	$11.08M	$15.16M	$15.16M
YoY Change	-38.72%	-23.0%	-23.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$198.2K	$223.0K	$223.0K
YoY Change	-32.99%	17.15%	17.15%
Accrued Expenses	$107.6K	$161.5K	$595.7K
YoY Change	-68.76%	-89.41%	-60.95%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$620.0K	$1.520M	$1.520M
YoY Change	-3.18%	-11.42%	-11.42%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$177.0K	$163.0K	$163.0K
YoY Change	-42.15%	-66.57%	-66.57%
Total Long-Term Liabilities	$176.9K	$163.0K	$163.0K
YoY Change	-42.15%	-66.57%	-66.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$620.0K	$1.520M	$1.520M
Total Long-Term Liabilities	$176.9K	$163.0K	$163.0K
Total Liabilities	$797.0K	$1.683M	$1.683M
YoY Change	-15.78%	-23.62%	-23.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$8.914M	-$5.683M
YoY Change	1124.22%	680.48%
Common Stock	$12.27K	$92.53K
YoY Change	-85.13%	17.45%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$25.24K	$25.24K
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.28M	$13.48M	$13.48M
YoY Change
Total Liabilities & Shareholders Equity	$11.08M	$15.16M	$15.16M
YoY Change	-38.72%	-23.0%	-23.0%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$2.114M	-$1.267M	-$3.766M
YoY Change	-7441.05%	-33.43%	277.55%
Depreciation, Depletion And Amortization	$245.9K	$187.1K	$1.214M
YoY Change	143.6%	116.54%	982.36%
Cash From Operating Activities	-$2.388M	-$1.925M	-$5.471M
YoY Change	29.89%	129.29%	642.31%
INVESTING ACTIVITIES
Capital Expenditures	$38.00K	$159.2K	$76.64K
YoY Change	-72.73%	314.88%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$38.00K	-$159.2K	-$484.8K
YoY Change	-72.73%	314.88%	961.89%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change
Common Stock Issuance & Retirement, Net			$1.210M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-25.24K	-$25.24K
YoY Change		-100.2%	-100.2%
NET CHANGE
Cash From Operating Activities	-2.388M	-1.925M	-$5.471M
Cash From Investing Activities	-38.00K	-159.2K	-$484.8K
Cash From Financing Activities		-25.24K	-$25.24K
Net Change In Cash	-2.426M	-2.109M	-$5.981M
YoY Change	160.48%	-117.65%	-151.71%
FREE CASH FLOW
Cash From Operating Activities	-$2.388M	-$1.925M	-$5.471M
Capital Expenditures	$38.00K	$159.2K	$76.64K
Free Cash Flow	-$2.426M	-$2.084M	-$5.547M
YoY Change	22.66%	137.41%	652.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Assets Assets	15164447	usd
CY2022Q4	us-gaap	Assets Assets	18583377	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	223040	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	190387	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	434152	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	344510	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1519964	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	964326	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1917315	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4279986	usd
CY2022	us-gaap	Interest Expense InterestExpense	24426	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2277816	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1046020	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1090556	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2939041	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	832072	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	92533	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	78783	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19097445	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18140520	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6201137	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12181799	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	816364	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421362	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001807887
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7878419	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9253419	shares
CY2020Q4	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.05	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41515
CY2023	dei	Entity Registrant Name EntityRegistrantName	Laser Photonics Corporation
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-3628771
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1101 N. Keller Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite G
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32810
CY2023	dei	City Area Code CityAreaCode	407
CY2023	dei	Local Phone Number LocalPhoneNumber	804 1000
CY2023	dei	Security12g Title Security12gTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	LASE
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9270419	shares
CY2023	dei	Auditor Firm AuditorFirmId	5525
CY2023	dei	Auditor Name AuditorName	Fruci & Associates II, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	5525
CY2023	dei	Auditor Location AuditorLocation	Spokane, Washington
CY2023Q4	us-gaap	Other Assets OtherAssets	39190	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	72527	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	9334507	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13721708	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	701234	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	161538	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	429429	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	162991	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	487562	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	162991	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	487562	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1682955	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1451888	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9253419	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7878419	shares
CY2022Q4	us-gaap	Shares Issued SharesIssued	829500	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5683246	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	25240	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2023Q4	laser	Stockholders Equity Deficit StockholdersEquityDeficit	13481492	usd
CY2022Q4	laser	Stockholders Equity Deficit StockholdersEquityDeficit	17131488	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15164447	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18583376	usd
CY2023	us-gaap	Revenues Revenues	3939474	usd
CY2022	us-gaap	Revenues Revenues	3894901	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	1489458	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1954328	usd
CY2023	us-gaap	Other Income OtherIncome	0	usd
CY2022	us-gaap	Other Income OtherIncome	7169	usd
CY2023	us-gaap	Gross Profit GrossProfit	2450016	usd
CY2022	us-gaap	Gross Profit GrossProfit	1947742	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1996363	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1677976	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1902760	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	894521	usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	523380	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	437832	usd
CY2023	laser	Payroll Expenses PayrollExpenses	1400951	usd
CY2022	laser	Payroll Expenses PayrollExpenses	887852	usd
CY2023	us-gaap	Other Expenses OtherExpenses	220298	usd
CY2022	us-gaap	Other Expenses OtherExpenses	18397	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	202259	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	100802	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6246011	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4017380	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3795995	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2069638	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	30063	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	0	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3765932	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2094064	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3765932	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2094064	usd
CY2023	laser	Earnings Per Share Basic Amount EarningsPerShareBasicAmount	-0.45
CY2022	laser	Earnings Per Share Basic Amount EarningsPerShareBasicAmount	-0.37
CY2023	laser	Earnings Per Share Fully Diluted EarningsPerShareFullyDiluted	-0.45
CY2022	laser	Earnings Per Share Fully Diluted EarningsPerShareFullyDiluted	-0.37
CY2023	laser	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	8934035	shares
CY2022	laser	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	5687049	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	5468365	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2094064	usd
CY2022	laser	Ipo Amount IpoAmount	12927688	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	829500	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	17131489	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3765932	usd
CY2023	laser	Stock Issued For License Agreement Amount StockIssuedForLicenseAgreementAmount	1210000	usd
CY2023	laser	Distributions To Affiliate DistributionsToAffiliate	-1214325	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	145500	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	13481492	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-3765932	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-2094064	usd
CY2023	laser	Shares Issued On Conversion Of Debt Amount SharesIssuedOnConversionOfDebtAmount	0	usd
CY2022	laser	Shares Issued On Conversion Of Debt Amount SharesIssuedOnConversionOfDebtAmount	0	usd
CY2023	laser	Shares To Be Issued As Consideration For Services Amount SharesToBeIssuedAsConsiderationForServicesAmount	829500	usd
CY2023	laser	Stock Issued During Period Shares Share Based Compensation Amount StockIssuedDuringPeriodSharesShareBasedCompensationAmount	145550	usd
CY2022	laser	Stock Issued During Period Shares Share Based Compensation Amount StockIssuedDuringPeriodSharesShareBasedCompensationAmount	0	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1214325	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	523380	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	437832	usd
CY2023	laser	Net Change Right Of Use Assets And Liabilities NetChangeRightOfUseAssetsAndLiabilities	-31775	usd
CY2022	laser	Net Change Right Of Use Assets And Liabilities NetChangeRightOfUseAssetsAndLiabilities	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-395002	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-311192	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1231796	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	744932	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	32910	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-54722	usd
CY2023	laser	Increase Decrease Stock Account During The Year IncreaseDecreaseStockAccountDuringTheYear	0	usd
CY2022	laser	Increase Decrease Stock Account During The Year IncreaseDecreaseStockAccountDuringTheYear	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32653	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	84894	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-267464	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	391218	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	701234	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	91775	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5470618	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-63376	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	76636	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	689250	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
CY2023	laser	Payments To Acquire Research And Development Equipment PaymentsToAcquireResearchAndDevelopmentEquipment	0	usd
CY2022	laser	Payments To Acquire Research And Development Equipment PaymentsToAcquireResearchAndDevelopmentEquipment	0	usd
CY2023	laser	Demonstration Equipment DemonstrationEquipment	0	usd
CY2022	laser	Demonstration Equipment DemonstrationEquipment	0	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	408169	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-484805	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-689250	usd
CY2023	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-261684	usd
CY2022	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-317328	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	-25240	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	12897688	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25240	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12318676	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5980663	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11566050	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	615749	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6201136	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12181799	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1210000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-109496	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	39509	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	24426	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at dates of the financial statements and the reported amounts of revenue and expenses during the periods. Actual results could differ from these estimates. Our significant estimates and assumptions include depreciation and the fair value of our stock, stock-based compensation, debt discount and the valuation allowance relating to the Company’s deferred tax assets.</p>
CY2023	laser	Cd Account CdAccount	6000000	usd
CY2023Q4	us-gaap	Cash Cash	6201137	usd
CY2022Q4	us-gaap	Cash Cash	12181799	usd
CY2023Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	5951137	usd
CY2023Q4	laser	Fdic Insurability FdicInsurability	250000	usd
CY2022Q4	laser	Fdic Insurability FdicInsurability	11931799	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	816364	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	421362	usd
CY2022Q4	laser	Allowance Estimated Credit Losses AllowanceEstimatedCreditLosses	18397	usd
CY2023Q4	laser	Allowance Estimated Credit Losses AllowanceEstimatedCreditLosses	216083	usd
CY2023Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	862941	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	759930	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1033104	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	254656	usd
CY2023Q4	laser	Inventory Sales Demo InventorySalesDemo	162958	usd
CY2022Q4	laser	Inventory Sales Demo InventorySalesDemo	0	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	243029	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	31434	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	24216	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2277816	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1046020	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	24216	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	101698	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	729956	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	483800	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	952811	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1090556	usd
CY2023Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	952811	usd
CY2022Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	1090556	usd
CY2023	us-gaap	Depreciation Depreciation	267381	usd
CY2022	us-gaap	Depreciation Depreciation	204733	usd
CY2023	laser	Property Plant And Equipment Estimated Useful Life PropertyPlantAndEquipmentEstimatedUsefulLife	P15Y
CY2023Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	4279986	usd
CY2022Q4	us-gaap	Intangible Assets Current IntangibleAssetsCurrent	2939041	usd
CY2023	laser	Earning Per Share Diluted EarningPerShareDiluted	0.45
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	233099	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	255999	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	725228	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	469229	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4279986	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2939041	usd
CY2023	laser	Annual Interest AnnualInterest	0.065	pure
CY2023Q4	laser	Sales Tax Liability SalesTaxLiability	106	usd
CY2022Q4	laser	Sales Tax Liability SalesTaxLiability	0	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	223040	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	190387	usd
CY2023	laser	Deferred Revenuepolicytextblock DeferredRevenuepolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Deferred Revenue is primarily comprised of products that have been made available to key distributors that has not been sold. As of December 31, 2023 the Company had $ 701,234, and December 31, 2022 the Company’s deferred revenue liabilities were recorded at zero. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of December 31, 2023, there were no loan balances owed by the Company.</p>
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	701234	usd
CY2023	laser	Shares Available To Potentially Issued SharesAvailableToPotentiallyIssued	180000	shares
CY2022	laser	Shares Available To Potentially Issued SharesAvailableToPotentiallyIssued	25000	shares
CY2022	laser	Earning Per Share Diluted EarningPerShareDiluted	0.37
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	18397	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	216083	usd
CY2023	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	4688695	shares
CY2023	us-gaap	Debt Conversion Original Debt Interest Rate Of Debt DebtConversionOriginalDebtInterestRateOfDebt	0.587	pure
CY2023Q2	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	25000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Unit Issued CommonUnitIssued	7878417	shares
CY2023Q4	us-gaap	Common Unit Issued CommonUnitIssued	9253417	shares
CY2023Q4	laser	Stockholders Equity Other Equity StockholdersEquityOtherEquity	13481492	usd
CY2022Q4	laser	Stockholders Equity Other Equity StockholdersEquityOtherEquity	17131488	usd
CY2023Q4	laser	Stockholders Equity Other Equity18 StockholdersEquityOtherEquity18	24937	shares
CY2023Q4	laser	Service Charge Expense ServiceChargeExpense	250	usd
CY2023Q4	laser	Total Cost TotalCost	33810	usd
CY2023	laser	Warrants Execution Price Beginning WarrantsExecutionPriceBeginning	6	usd
CY2023	laser	Warrants Execution Price Ending WarrantsExecutionPriceEnding	6	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	25000	shares
CY2022Q3	laser	Stock Option Exercise Price StockOptionExercisePrice	5.00
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2024-10-31
CY2021	us-gaap	Variable Lease Payment VariableLeasePayment	15109	usd
CY2023	us-gaap	Variable Lease Payment VariableLeasePayment	10000	usd
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25109	usd
CY2022	us-gaap	Variable Lease Payment VariableLeasePayment	14805	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	597143	usd
CY2023Q4	laser	Operating Lease Liability Amount OperatingLeaseLiabilityAmount	434153	usd
CY2023Q4	laser	Operating Lease Liability Non Current Amount OperatingLeaseLiabilityNonCurrentAmount	162990	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	434153	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	162990	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	597143	usd

Files In Submission

Name	View Source	Status
0001654954-24-004797-index-headers.html	Edgar Link	pending
0001654954-24-004797-index.html	Edgar Link	pending
0001654954-24-004797.txt	Edgar Link	pending
0001654954-24-004797-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
laser-20231231.xsd	Edgar Link	pending
laser_10k.htm	Edgar Link	pending
laser_10kimg10.jpg	Edgar Link	pending
laser_10kimg2.jpg	Edgar Link	pending
laser_10kimg3.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
laser-20231231_cal.xml	Edgar Link	unprocessable
laser-20231231_def.xml	Edgar Link	unprocessable
laser-20231231_pre.xml	Edgar Link	unprocessable
laser-20231231_lab.xml	Edgar Link	unprocessable
laser_10kimg4.jpg	Edgar Link	pending
laser_10kimg5.jpg	Edgar Link	pending
laser_10kimg6.jpg	Edgar Link	pending
laser_10kimg7.jpg	Edgar Link	pending
laser_10kimg8.jpg	Edgar Link	pending
laser_ex311.htm	Edgar Link	pending
laser_ex312.htm	Edgar Link	pending
laser_ex321.htm	Edgar Link	pending
laser_ex322.htm	Edgar Link	pending
laser_ex971.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
laser_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LASE
Laser Photonics Corp Stock $lase

2024 Q2 Form 10-K Financial Statement

#000165495424004797 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE Laser Photonics Corp Stock $lase

2024 Q2 Form 10-K Financial Statement

#000165495424004797 Filed on April 19, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LASE
Laser Photonics Corp Stock $lase